Telemedica Boosts Real-World Evidence Platform with New Funding Round

Telemedica has announced a new funding round to help support its real-world evidence (RWE) and real-world data (RWD) offerings. The funding round netted the company almost $26 billion, bringing Telemedica’s total funds raised to $43.4 million. The company’s plans to integrate its Permia RWE platform with its patient apps.

According to Medical Device Network, “The Temedica ecosystem combines data from different sources, including patient experience data, insurance data, medically relevant product sales data, registry data, and patient-generated data from patient companion apps. The insights obtained from the connected data provide real-world evidence data to healthcare system stakeholders, including research institutions, healthcare specialists, pharmacies, pharmaceutical and biotechnology companies, patients, and clinics.”

To read more, click here.

(Source: Medical Device Network, November 24^th, 2022)